Literature DB >> 3228636

Release of creatine kinase from skeletal muscles by Bothrops venoms: heparin potentiation of inhibition by antivenin.

P A Melo1, G Suarez-Kurtz.   

Abstract

The glycosaminoglycan, heparin (50 micrograms/ml) inhibited the increase in creatine kinase (CK) released from rat extensor digitorum longus (EDL) muscles exposed to Bothrops jararaca venom (150 micrograms/ml). Heparin (2 micrograms/ml) and polyvalent antivenin (0.5 microliter/ml) did not affect the increase in CK release induced by exposure of the muscles to 50 micrograms/ml B. jararacussu venom. Simultaneous exposure of the muscles to venom plus heparin (2 micrograms/ml) plus antivenin (0.5 or 1 microliter/ml) reduced CK release after 160 min by 50% and 80% compared to that induced by venom alone. These changes in CK release from rat EDL muscle show that heparin inhibits the myotoxic effects of Bothrops venoms and increases the potency of their antivenin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3228636

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

1.  Heparin at low concentration acts as antivenom against Bothrops jararacussu venom and bothropstoxin-I neurotoxic and myotoxic actions.

Authors:  Sandro Rostelato-Ferreira; Gildo Bernardo Leite; Adélia Cristina Oliveira Cintra; Maria Alice da Cruz-Höfling; Léa Rodrigues-Simioni; Yoko Oshima-Franco
Journal:  J Venom Res       Date:  2010-10-15

2.  Pulsed ultrasound therapy accelerates the recovery of skeletal muscle damage induced by Bothrops jararacussu venom.

Authors:  J Saturnino-Oliveira; M A Tomaz; T F Fonseca; G A Gaban; M Monteiro-Machado; M A Strauch; B L Cons; S Calil-Elias; A M B Martinez; P A Melo
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

3.  Abarema cochliacarpos extract decreases the inflammatory process and skeletal muscle injury induced by Bothrops leucurus venom.

Authors:  Jeison Saturnino-Oliveira; Daiana Do Carmo Santos; Adriana Gibara Guimarães; Antônio Santos Dias; Marcelo Amorim Tomaz; Marcos Monteiro-Machado; Charles Santos Estevam; Waldecy De Lucca Júnior; Durvanei Augusto Maria; Paulo A Melo; Adriano Antunes de Souza Araújo; Márcio Roberto Viana Santos; Jackson Roberto Guedes da Silva Almeida; Rita de Cássia Meneses Oliveira; Aldeidia Pereira de Oliveira; Lucindo José Quintans Júnior
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

4.  A Novel Apilic Antivenom to Treat Massive, Africanized Honeybee Attacks: A Preclinical Study from the Lethality to Some Biochemical and Pharmacological Activities Neutralization.

Authors:  Jhonatha Mota Teixeira-Cruz; Marcelo Abrahão Strauch; Marcos Monteiro-Machado; Matheus Silva Tavares-Henriques; João Alfredo de Moraes; Luís Eduardo Ribeiro da Cunha; Rui Seabra Ferreira; Benedito Barraviera; Luis Eduardo M Quintas; Paulo A Melo
Journal:  Toxins (Basel)       Date:  2021-01-05       Impact factor: 4.546

5.  Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.

Authors:  Marcelo A Strauch; Marcelo Amorim Tomaz; Marcos Monteiro-Machado; Bruno Lemos Cons; Fernando Chagas Patrão-Neto; Jhonatha da Mota Teixeira-Cruz; Matheus da Silva Tavares-Henriques; Pâmella Dourila Nogueira-Souza; Sara L S Gomes; Paulo R R Costa; Edgar Schaeffer; Alcides J M da Silva; Paulo A Melo
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.